Cathepsin D in ovarian cancer:: prognostic value and correlation with p53 expression and microvessel density

被引:51
|
作者
Lösch, A
Schindl, M
Kohlberger, P
Lahodny, J
Breitenecker, G
Horvat, R
Birner, P
机构
[1] Univ Vienna, Clin Inst Pathol, A-1090 Vienna, Austria
[2] Univ Vienna, Dept Gynecol & Obstet, A-1090 Vienna, Austria
[3] Hosp St Polten, Dept Gynecol & Obstet, A-3100 St Polten, Austria
关键词
cathepsin D; ovarian cancer; prognosis; p53; angiogenesis;
D O I
10.1016/j.ygyno.2003.11.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Overexpression of ubiquitous lysosomal aspartyl protease cathepsin D (CD) is involved in the progression of cancer. This study investigates the prognostic value and the association of cathepsin D expression with clinicopathological parameters, p53 expression, and angiogenesis in ovarian cancer. Methods. Cathepsin D was determined immunohistochemically in 43 ovarian tumors of low malignant potential (LMP) and 80 invasive tumors FIGO stage I-IV. Results were correlated with clinicopathological characteristics, p53, and microvessel density (MVD). Survival analysis of cathepsin D expression and MVD was performed in invasive tumors. Results. Epithelial tumor cathepsin D expression was more common in LMP tumors (65.1%) compared to invasive tumors (43.7%; P = 0.02). In LMP tumors, stromal cathepsin D was associated with mucinous tumors (P = 0.01), whereas in invasive tumors, epithetial cathepsin D expression was associated with clear cell tumors (P = 0.003). Invasive tumor cathepsin D had a negative relation to p53 expression. In LMP tumors, stromal cathepsin D correlated with microvessel density (P = 0.03). Stromal cathepsin D expression was an independent prognostic factor for disease-free survival (DFS) in patients with invasive cancer (P = 0.03, Cox regression), while cathepsin D expression missed to be of prognostic value for overall survival (OS) in invasive ovarian cancer. MVD had no influence on survival in invasive ovarian cancer (P > 0.05). Conclusion. Our study demonstrates a prognostic value of cathepsin D expression in invasive ovarian cancer, while cathepsin D expression in LMP rumors seems to be linked to angiogenesis. The relation among cathepsin D, p53 expression, and angiogenesis demonstrates biological differences between invasive ovarian cancer and LMP tumors. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:545 / 552
页数:8
相关论文
共 50 条
  • [31] Comparison of p53 expression in proximal and distal gastric cancer: Histopathologic correlation and prognostic significance
    Tang, HH
    Hokita, S
    Che, XM
    Baba, M
    Aridome, K
    Kijima, F
    Tanabe, G
    Takao, S
    Aikou, T
    ANNALS OF SURGICAL ONCOLOGY, 1997, 4 (06) : 470 - 474
  • [32] Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study
    Rubatt, Jennifer M.
    Darcy, Kathleen M.
    Hutson, Alan
    Bean, Sarah M.
    Havrilesky, Laura J.
    Grace, Lisa A.
    Berchuck, Andrew
    Secord, Angeles Alvarez
    GYNECOLOGIC ONCOLOGY, 2009, 112 (03) : 469 - 474
  • [33] EXPRESSION OF THE P53 GENE AND PRESENCE OF SERUM AUTOANTIBODIES IN OVARIAN-CANCER - CORRELATION WITH DIFFERENTIATION
    GREEN, JA
    ROBERTSON, LJ
    CAMPBELL, IR
    JENKINS, J
    CANCER DETECTION AND PREVENTION, 1995, 19 (02): : 151 - 155
  • [34] Lack of prognostic value of p53 protein expression in node-negative breast cancer
    Bianchi, S
    Calzolari, A
    Vezzosi, V
    Zampi, G
    Cardona, G
    Cataliotti, L
    Bonardi, R
    Ciatto, S
    TUMORI, 1997, 83 (03) : 669 - 672
  • [35] Prognostic value of cyclin E and p53 expression in gastric carcinoma
    Sakaguchi, T
    Watanabe, A
    Sawada, H
    Yamada, Y
    Yamashita, J
    Matsuda, M
    Nakajima, M
    Miwa, T
    Hirao, T
    Nakano, H
    CANCER, 1998, 82 (07) : 1238 - 1243
  • [36] Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer
    G Hofstetter
    A Berger
    H Fiegl
    N Slade
    A Zorić
    B Holzer
    E Schuster
    V J Mobus
    D Reimer
    G Daxenbichler
    C Marth
    A G Zeimet
    N Concin
    R Zeillinger
    Oncogene, 2010, 29 : 1997 - 2004
  • [37] Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinicopathological features in colon cancer
    Perrone, G
    Vincenzi, B
    Santini, D
    Verzì, A
    Tonini, G
    Vetrani, A
    Rabitti, C
    CANCER LETTERS, 2004, 208 (02) : 227 - 234
  • [38] Clinical prognostic values of vascular endothelial growth factor, microvessel density, and p53 expression in esophageal carcinomas
    Ahn, MJ
    Jang, SJ
    Park, YW
    Choi, JH
    Oh, HS
    Lee, CB
    Paik, HK
    Park, CK
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2002, 17 (02) : 201 - 207
  • [39] Prognostic and predictive value of p53 and p21 in breast cancer
    Elledge, RM
    Allred, DC
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) : 79 - 98
  • [40] P53 ASSOCIATED WITH CATHEPSIN-D IN PRIMARY BREAST-CANCER
    MARSIGLIANTE, S
    LEO, G
    MOTTAGHI, A
    BISCOZZO, L
    GRECO, S
    STORELLI, C
    INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1993, 23 (02) : 102 - 108